Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
08/2005
08/24/2005EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof
08/24/2005EP1565458A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/24/2005EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions
08/24/2005EP1565218A2 Molecules preferentially associated with effector t cells and methods of their use
08/24/2005EP1565214A2 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors
08/24/2005EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation
08/24/2005EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy
08/24/2005EP1565198A2 Anti-angiogenesis effects of morinda citrifolia
08/24/2005EP1565181A2 Deguelin as a chemopreventive agent for lung cancer
08/24/2005EP1565136A2 Compositions and methods for transdermal oxybutynin therapy
08/24/2005EP1504019B1 Platinum complexes having antitumor activity
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005CN1659281A Antiviral therapy on the basis of RNA interference
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659137A N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
08/24/2005CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/23/2005US6932962 for use in pressurized metered dose inhalers (pMDI's); surfactants such as decyl glucoside or dodecyl maltoside
08/18/2005WO2005074902A1 Rectal composition
08/18/2005WO2005074720A1 Use and composition of a powder of high melting fatty substance to induce a prolonged satiety feeling
08/18/2005WO2005055943A3 Vinorelbine derivatives
08/18/2005WO2005055930A3 Recombinant factor viii having increased specific activity
08/18/2005WO2005055921A3 Compositions for treatment of ear disorders and methods of use thereof
08/18/2005WO2005053613A3 Combinations for the treatment of fungal infections
08/18/2005WO2005053608A3 Preparing for individualized dosage forms of medicaments
08/18/2005WO2005046601A3 4-phenyl piperdine sulfonyl glycine transporter inhibitors
08/18/2005WO2005044197A3 Synthesis of glycopeptides with superior pharmacokinetic properties
08/18/2005WO2005044179A8 Formulations containing astragalus extracts and uses thereof
08/18/2005WO2005037217A3 Lentiviral vector delivery of msp36 for treatment of cancer
08/18/2005WO2005027846A3 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
08/18/2005WO2005027841A3 Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
08/18/2005WO2005025493A3 Biological engineering of articular structures containing both cartilage and bone
08/18/2005WO2005020924A3 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
08/18/2005WO2005018549A3 Methods and compositions for tissue repair
08/18/2005WO2005013909A3 Novel cathepsin k inhibitors
08/18/2005WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/18/2005WO2005004799A3 β-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF
08/18/2005WO2004112712A3 Speculum assembly
08/18/2005WO2004100898A3 Therapeutic use of anti-cs1 antibodies
08/18/2005WO2004100873A3 Compounds, compositions, and methods
08/18/2005WO2004091527A3 Delivery systems of homogeneous thermoreversible low viscosity polymannan gum films
08/18/2005WO2004091490A3 Somatostatin-dopamine chimeric analogs
08/18/2005WO2004084821A3 Hemipteran glutamate decarboxylase
08/18/2005WO2004066946A3 Method for evaluating the efficacy of certain cancer treatments
08/18/2005WO2004054516A3 Antagonists for human prolactin
08/18/2005WO2004047763A3 Production of ubiquinones
08/18/2005WO2004028458A3 Antisense modulation of microsomal prostaglandin e2 synthase expression
08/18/2005US20050182140 Antimicrobial compositions
08/18/2005US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus
08/18/2005US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
08/18/2005US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus
08/18/2005US20050181494 Novel lambda phage display system and the process
08/18/2005US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus
08/18/2005US20050181105 Producing hollow tubular fibers from legume hulls and utilizing such fibers for enhancing flavors and aromas and imparting time-release capabilities for pharmaceuticals and nutraceuticals
08/18/2005US20050181077 Composition treating for AIDS and associated conditions
08/18/2005US20050180962 treating a non-alcoholic fatty liver disease; inactivated probiotic bacteria; and a pharmaceutically acceptable excipient; gastrointestinal inflammation; allergic asthma
08/17/2005EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
08/17/2005EP1563301A2 Method for the prevention of malaria
08/17/2005EP1563237A2 Freeze-drying microscope stage apparatus and process of using the same
08/17/2005EP1563066A2 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
08/17/2005EP1562977A2 Active specific immunotherapy of cancer metastasis
08/17/2005EP1562930A2 Synthetic lactone formulations and method of use
08/17/2005EP1562641A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
08/17/2005EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses
08/17/2005EP1562590A2 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls
08/17/2005EP1562587A2 Novel compositions and methods for the treatment of immune related diseases
08/17/2005EP1562555A2 Sustained release l-arginine formulations and methods of manufacture and use
08/17/2005EP1562423A2 Compositions and methods for prevention of photoaging
08/17/2005EP1311256B1 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
08/17/2005EP1011646B1 Pharmaceutical compositions and devices for their administration
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656178A Oil-soluble pigment compositions
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1656067A New salts
08/17/2005CN1655824A Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
08/17/2005CN1655764A Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/16/2005CA2098533C Carrier system against gnrh
08/11/2005WO2005073393A1 Systems and methods for blood glucose sensing
08/11/2005WO2005072730A1 Therapeutic agent for diarrhea-type irritable bowel syndrome
08/11/2005WO2005072720A1 Use of phenylbutyrate for treatment of spinal muscular atrophy
08/11/2005WO2005058247A3 Method for preparing radiolabeled thymidine having low chromophoric byproducts
08/11/2005WO2005055937A3 Branched sulfates with improved odor properties and their use in personal care compositions
08/11/2005WO2005053617A3 Compositions and methods comprising collagen
08/11/2005WO2005051325A3 Carvedilol compositions methods of treatment and delivery
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005051298A3 Novel phosphorus-containing thyromimetics
08/11/2005WO2005048919A3 Preventative effects of morinda citrifolia on mammary breast cancer
08/11/2005WO2005046617A3 Compositions and methods for reducing microbial induced apoptosis
08/11/2005WO2005046588A3 Compounds, compositions, and methods
08/11/2005WO2005041892A3 Purine receptor inhibition as a therapeutic strategy in spinal cord and brain
08/11/2005WO2005041877A9 Method of inhibiting rejection following organ transplantation
08/11/2005WO2005041876A3 Spill resistant formulations containing clays
08/11/2005WO2005041858A3 Mucin production inhibitor
08/11/2005WO2005039504A3 Compounds and methods for treating toll-like receptor 2-related diseases and conditions
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005032472A3 Pyrrolidine and piperidine derivatives as factor xa inhibitors
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 295